India’s pharma market, valued around INR 2.17 lakh crore, faces mounting profit pressure as fake drugs erode trust and government Jan Aushadhi initiatives intensify competition. Industry voices point to early signs of fatigue, but many insist the sector isn’t collapsing and a rebound could still be on the horizon if enforcement and demand dynamics improve.
Telangana’s drug administration has uncovered a tightly run spurious drug network stretching from Uttarakhand to parts of Hyderabad, with alleged operational roots traced back to south India. Police sources call the seizure “just the tip of an iceberg,” warning the broader supply chain may still be active. Investigations are now aimed at identifying the full network behind the racket.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
